Optimal treatment for relapsing ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/21/suppl_7/vii218/19446562/mdq377.pdf
Reference41 articles.
1. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments;Kyrgiou;J Natl Cancer Inst,2006
2. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses;Lee;Gynecol Oncol,2005
3. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial;International Collaboration for Ovarian Neoplasia Group;Lancet,2003
4. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG;Pfisterer;J Clin Oncol,2006
5. Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer;Monk;J clin Oncol,2010
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ ĐIỀU TRỊ UNG THƯ BIỂU MÔ BUỒNG TRỨNG TÁI PHÁT TẠI BỆNH VIỆN TỪ DŨ;Tạp Chí Khoa Học Trường Đại Học Quốc Tế Hồng Bàng;2024-05-24
2. Guanylate-binding protein 1 modulates proteasomal machinery in ovarian cancer;iScience;2023-11
3. Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer;Cancers;2023-04-06
4. Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer;Gynecologic Oncology;2023-03
5. BRCA mutation carriers suffering from ovarian cancer as a model for treatment decision in higher lines – Place for platinum reinduction;Journal of Cancer Research and Therapeutics;2022-11-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3